Literature DB >> 17574554

Differential involvement of nitric oxide signaling in dopamine and PACAP stimulation of growth hormone release in goldfish.

Gabriel Mitchell1, Grant R Sawisky, Caleb L Grey, Calvin J Wong, Aubrey D Uretsky, John P Chang.   

Abstract

Previous studies in goldfish pituitary cells have shown that nitric oxide synthase (NOS)/nitric oxide (NO) signaling is involved in mediating the growth hormone (GH) release response to gonadotropin-releasing hormones. In this study, the involvement of this signaling pathway in mediating the action of two cAMP-mobilizing neuroendocrine stimulators of GH release, pituitary adenylate cyclase-activating polypeptide (PACAP) and dopamine (DA), was investigated in cell column perifusion experiments with primary cultures of dispersed pituitary cells. GH responses to PACAP were unaffected by three NOS inhibitors, aminoguanidine hemisulfate, 1400W and 7-nitroindazole (7-Ni). PACAP-stimulated GH release was also not reduced by two NO scavengers, rutin hydrate and PTIO, but NO-donor sodium nitroprusside (SNP)-elicited GH release was additive to the GH response to PACAP. In contrast, DA-induced GH secretion was reduced by 7-Ni, rutin hydrate and PTIO while not being additive to the GH response induced by SNP. These results indicate that although both PACAP and DA stimulation of acute GH release involve activation of adenylate cyclase/cAMP, DA- but not PACAP-signaling also utilizes the NOS/NO second messenger system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574554     DOI: 10.1016/j.ygcen.2007.05.007

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  1 in total

1.  PACAP/GCGa Is an Important Modulator of the Amphioxus CNS-Hatschek's Pit Axis, the Homolog of the Vertebrate Hypothalamic-Pituitary Axis in the Basal Chordates.

Authors:  Jason S W On; Liuru Su; Hong Shen; Aloysius W R Arokiaraj; João C R Cardoso; Guang Li; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.